NCT02040636: Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis |
|
|
| Completed | 2 | 277 | Canada | Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV, TdcP-IPV, Hepatitis B vaccine, Recombivax HB® | Sanofi Pasteur, a Sanofi Company | Pertussis, Tetanus, Diphtheria, Poliomyelitis, Hepatitis B | 05/00 | 05/00 | | |
NCT00551915: A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003) |
|
|
| Completed | 2 | 756 | Europe | AR51 (12, 10), PR51 (3, 10), PR51 (6, 10), PENTACEL™, RECOMBIVAX HB™ | Merck Sharp & Dohme LLC | Bacterial Infections; Virus Diseases | 01/03 | 01/03 | | |
| Completed | 2 | 566 | NA | Comparator: RECOMBIVAX HB™, Comparator: Modified process Hepatitis B Vaccine | Merck Sharp & Dohme LLC | Hepatitis B, Hepatocellular Carcinoma | 07/07 | 07/07 | | |
